Results 281 to 290 of about 222,802 (316)
Some of the next articles are maybe not open access.
Complications of Anticoagulation
Disease-a-Month, 2012The most common complication of heparin therapy is bleeding. Patient actors that increase the risk of bleeding include recent surgery or trauma, dvanced age (ie, age older than 65 years), alcoholism, aspirin use, bed est, immobility, obesity, congestive heart failure, cancer, hypercoagulale states (thrombophilia), childbirth, and pharmacologic doses of
Ozlem, Bilen, Jun, Teruya
openaire +2 more sources
Blood Reviews, 1991
Acquired antibodies to phospholipids form a heterogeneous group, which may be detected in vitro by the inhibition of phospholipid dependent tests of coagulation (lupus anticoagulant) and also by immunological assays, such that a combined approach is required for their reliable detection.
M D, Creagh, M, Greaves
openaire +2 more sources
Acquired antibodies to phospholipids form a heterogeneous group, which may be detected in vitro by the inhibition of phospholipid dependent tests of coagulation (lupus anticoagulant) and also by immunological assays, such that a combined approach is required for their reliable detection.
M D, Creagh, M, Greaves
openaire +2 more sources
Clinics in Laboratory Medicine, 2009
This article reviews the commonly used anticoagulants (warfarin and heparin) and associated recommended laboratory testing. Emphasis is on the various modes of International Normalized Ratio testing and associated variability (clinical laboratory, point of care, patient self-testing).
openaire +2 more sources
This article reviews the commonly used anticoagulants (warfarin and heparin) and associated recommended laboratory testing. Emphasis is on the various modes of International Normalized Ratio testing and associated variability (clinical laboratory, point of care, patient self-testing).
openaire +2 more sources
Pharmacology of Anticoagulants
Disease-a-Month, 2012Antithrombotic drugs are used for the prevention and treatment of thrombosis. Targeting the various components of thrombosis, these agents include (1) antiplatelet agents; (2) anticoagulants; and (3) fibrinolytic agents. This review focuses on anticoagulants.
Loke, Chandravathi, MD +2 more
openaire +2 more sources
Anticoagulants and Anticoagulation
Medical Clinics of North America, 1976M, Nussbaum, C B, Moschos
openaire +2 more sources
Anticoagulation: choosing the optimal anticoagulant.
FP essentials, 2014The risks of bleeding and thrombosis should be considered in decisions on whether to initiate anticoagulation therapy. Oral anticoagulation is indicated for patients with nonvalvular atrial fibrillation who are at intermediate or high risk of stroke (CHADS2 [Congestive heart failure, Hypertension, Age at least 75 years, Diabetes, previous Stroke or ...
Emily M, Hawes, Anthony J, Viera
openaire +1 more source
Potential anticoagulant of traditional chinese medicine and novel targets for anticoagulant drugs
Phytomedicine, 2023Wang Yin, Xiaoqin Zhang, Chunpeng Wan
exaly